Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ: BOLT · Real-Time Price · USD

5.76

+0.03 (0.52%)

At close: Oct 31, 2025, 4:00 PM EDT

5.72

-0.04 (-0.69%)

After-hours: Oct 31, 2025, 4:10 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Novel Immunotherapies	7.69M	Log In	Log In	Log In	Log In	Upgrade
Novel Immunotherapies Growth	-2.36%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	7.69M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-2.36%	Log In	Log In	Log In	Log In	Upgrade